JP2017509692A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017509692A5 JP2017509692A5 JP2016566866A JP2016566866A JP2017509692A5 JP 2017509692 A5 JP2017509692 A5 JP 2017509692A5 JP 2016566866 A JP2016566866 A JP 2016566866A JP 2016566866 A JP2016566866 A JP 2016566866A JP 2017509692 A5 JP2017509692 A5 JP 2017509692A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- patient
- dpp4
- antigen
- binding fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461931878P | 2014-01-27 | 2014-01-27 | |
| US61/931,878 | 2014-01-27 | ||
| US201461990932P | 2014-05-09 | 2014-05-09 | |
| US61/990,932 | 2014-05-09 | ||
| PCT/US2015/012885 WO2015112970A1 (en) | 2014-01-27 | 2015-01-26 | Dipeptidyl peptidase-4 (dpp4/cd26) as a peripheral biomarker of il-13 activation in asthmatic lung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017509692A JP2017509692A (ja) | 2017-04-06 |
| JP2017509692A5 true JP2017509692A5 (enExample) | 2018-03-08 |
Family
ID=53682019
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016566866A Pending JP2017509692A (ja) | 2014-01-27 | 2015-01-26 | 喘息肺におけるｉｌ−１３活性化の末梢バイオマーカーとしてのジペプチジルペプチターゼ４（ｄｐｐ４／ｃｄ２６） |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20160363591A1 (enExample) |
| EP (2) | EP3685857A1 (enExample) |
| JP (1) | JP2017509692A (enExample) |
| KR (1) | KR20160113700A (enExample) |
| CN (1) | CN105934254A (enExample) |
| AU (1) | AU2015209124A1 (enExample) |
| BR (1) | BR112016017192A2 (enExample) |
| CA (1) | CA2937387A1 (enExample) |
| MX (1) | MX2016009491A (enExample) |
| RU (1) | RU2016134838A (enExample) |
| SG (1) | SG11201606102UA (enExample) |
| WO (1) | WO2015112970A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20160122756A (ko) * | 2014-02-07 | 2016-10-24 | 메디뮨 엘엘씨 | 인간 페리오스틴을 검출하기 위한 신규 검정법 |
| AU2016205188A1 (en) | 2015-01-09 | 2017-06-22 | Medimmune, Llc | Assay to detect human DPP-4 |
| HK1255922A1 (zh) * | 2015-11-04 | 2019-09-06 | Astrazeneca Ab | 二肽基肽酶-4和骨膜素作为嗜酸性粒细胞疾病中嗜酸性粒细胞靶向治疗药物临床反应的预测因子 |
| WO2017189805A1 (en) | 2016-04-27 | 2017-11-02 | Abbvie Inc. | Methods of treatment of diseases in which il-13 activity is detrimental using anti-il-13 antibodies |
| CN107474134B (zh) | 2016-06-08 | 2021-07-27 | 苏州康乃德生物医药有限公司 | 用于结合白细胞介素4受体的抗体 |
| TWI787203B (zh) * | 2016-09-23 | 2022-12-21 | 美商建南德克公司 | Il-13拮抗劑用於治療異位性皮炎之用途 |
| CA3049847A1 (en) | 2017-02-24 | 2018-08-30 | Trustees Of Boston University | Isolation of human lung progenitors derived from pluripotent stem cells |
| CN109055522A (zh) * | 2018-07-03 | 2018-12-21 | 吉林大学 | C4orf38在制备用于检测或治疗神经性疼痛的产品中的应用 |
| KR102330596B1 (ko) * | 2018-11-09 | 2021-11-26 | 아주대학교산학협력단 | 인간 il-4 수용체 알파에 대한 고친화도 인간 항체 및 이의 용도 |
| CN113155996A (zh) * | 2021-03-23 | 2021-07-23 | 广州医科大学附属第一医院（广州呼吸中心） | 15(s)-羟基二十碳四烯酸在评估变应原特异性免疫治疗效果中的应用 |
| KR20250025381A (ko) | 2022-06-17 | 2025-02-21 | 아포지 바이오로직스, 인크. | 인터류킨 13에 결합하는 항체 및 사용 방법 |
| CN117554614A (zh) * | 2022-09-23 | 2024-02-13 | 上海市第十人民医院 | 蛋白生物标志物dpp4在克罗恩病临床诊断中的应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5892019A (en) | 1987-07-15 | 1999-04-06 | The United States Of America, As Represented By The Department Of Health And Human Services | Production of a single-gene-encoded immunoglobulin |
| WO2004104216A2 (en) * | 2003-05-21 | 2004-12-02 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with dipeptidylpeptidase iv (dpp4) |
| GB0407315D0 (en) * | 2003-07-15 | 2004-05-05 | Cambridge Antibody Tech | Human antibody molecules |
| EP1723257B1 (en) * | 2004-02-23 | 2019-01-09 | Erasmus University Medical Center Rotterdam | Classification, diagnosis and prognosis of acute myeloid leukemia by gene expression profiling |
| CA2672215A1 (en) * | 2006-12-11 | 2008-06-19 | Wyeth | Methods and compositions for treating and monitoring treatment of il-13-associated disorders |
| WO2008091814A2 (en) * | 2007-01-22 | 2008-07-31 | Wyeth | Assessment of asthma and allergen-dependent gene expression |
| US20120005206A1 (en) * | 2007-02-09 | 2012-01-05 | Konstantinos Anagnostakis | Apparatus and method for analysis of data traffic |
| AU2008316313B2 (en) * | 2007-10-23 | 2015-04-16 | Clinical Genomics Pty. Ltd. | A method of diagnosing neoplasms - II |
| NZ601815A (en) | 2008-03-31 | 2014-10-31 | Genentech Inc | Compositions and methods for treating and diagnosing asthma |
| US20100221752A2 (en) | 2008-10-06 | 2010-09-02 | Somalogic, Inc. | Ovarian Cancer Biomarkers and Uses Thereof |
| PL2627673T3 (pl) * | 2010-10-15 | 2018-01-31 | Medimmune Ltd | Terapie poprawiające funkcje płuc |
| KR101615420B1 (ko) | 2010-12-16 | 2016-04-26 | 제넨테크, 인크. | Th2 억제에 관한 진단 및 치료 |
| WO2012158954A1 (en) | 2011-05-18 | 2012-11-22 | Medimmune, Llc | Methods of diagnosing and treating pulmonary diseases or disorders |
-
2015
- 2015-01-26 WO PCT/US2015/012885 patent/WO2015112970A1/en not_active Ceased
- 2015-01-26 CA CA2937387A patent/CA2937387A1/en not_active Abandoned
- 2015-01-26 EP EP20158832.4A patent/EP3685857A1/en not_active Withdrawn
- 2015-01-26 US US15/114,467 patent/US20160363591A1/en not_active Abandoned
- 2015-01-26 RU RU2016134838A patent/RU2016134838A/ru not_active Application Discontinuation
- 2015-01-26 MX MX2016009491A patent/MX2016009491A/es unknown
- 2015-01-26 AU AU2015209124A patent/AU2015209124A1/en not_active Abandoned
- 2015-01-26 CN CN201580005884.2A patent/CN105934254A/zh active Pending
- 2015-01-26 KR KR1020167023637A patent/KR20160113700A/ko not_active Withdrawn
- 2015-01-26 SG SG11201606102UA patent/SG11201606102UA/en unknown
- 2015-01-26 JP JP2016566866A patent/JP2017509692A/ja active Pending
- 2015-01-26 EP EP15740660.4A patent/EP3099323A4/en not_active Withdrawn
- 2015-01-26 BR BR112016017192A patent/BR112016017192A2/pt not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cao et al. | Pirfenidone ameliorates silica-induced lung inflammation and fibrosis in mice by inhibiting the secretion of interleukin-17A | |
| O'Byrne et al. | Asthma progression and mortality: the role of inhaled corticosteroids | |
| RU2016134838A (ru) | Дипептидил пептидаза-4 (dpp4/cd26) как периферический биомаркер активации il-13 в астматическом легком | |
| Jonstam et al. | Dupilumab reduces local type 2 pro‐inflammatory biomarkers in chronic rhinosinusitis with nasal polyposis | |
| Buhl et al. | Severe eosinophilic asthma: a roadmap to consensus | |
| JP6457463B2 (ja) | 処置方法 | |
| Opina et al. | Phenotype-driven therapeutics in severe asthma | |
| Geng et al. | Biologic therapies for allergic rhinitis and nasal polyposis | |
| EP2627673B1 (en) | Therapies for improving pulmonary function | |
| JP2018533557A5 (enExample) | ||
| JP2018158934A (ja) | 抗ｉｌ−５抗体を投与するための方法 | |
| CN107073114B (zh) | 使用瑞利珠单抗治疗中度到重度嗜酸细胞性哮喘 | |
| Sposato et al. | Effects of omalizumab in severe asthmatics across ages: a real life Italian experience | |
| Staton et al. | A phase I, randomized, observer-blinded, single and multiple ascending-dose study to investigate the safety, pharmacokinetics, and immunogenicity of BITS7201A, a bispecific antibody targeting IL-13 and IL-17, in healthy volunteers | |
| Yilmaz et al. | Efficacy of mepolizumab treatment in oral corticosteroid-dependent severe eosinophilicasthma patients with chronic rhinosinusitis with nasal polyps: single center, real life study | |
| Tagaya et al. | Effect of tiotropium on mucus hypersecretion and airway clearance in patients with COPD | |
| KR20240049348A (ko) | 항-인터루킨-33 항체를 사용한 만성 폐쇄성 폐질환의 치료 | |
| Li | Targeting the IL-4/IL-4R axis in Th2 inflammatory diseases: a review of clinical efficacy and safety | |
| Selivanova et al. | Differential expression of the β2-adrenoreceptor and M3-cholinoreceptor genes in bronchial mucosa of patients with asthma and chronic obstructive pulmonary disease | |
| Rupani et al. | Eosinophilic asthma | |
| US11224653B2 (en) | Treatment strategy for non-responders to 100MG subcutaneous mepolizumab | |
| Mastalerz et al. | Effect of inhaled corticosteroids on small airway inflammation in patients with bronchial asthma | |
| Moslem et al. | Evaluation of Effectiveness of Dexamethasone versus Hydrocortisone in Reducing Hospital Length, Peak Expiratory Flow, Oxidative Stress Factors and Inflammatory Mediators in Chronic Obstructive Pulmonary Disease (COPD) Exacerbation Patients: A Randomized Controlled Trial | |
| MOELAMSYAH et al. | Late-Onset Asthma: A Review | |
| Butler et al. | Acute exacerbations of COPD |